VYNE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vyne Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.6329 USD 1.75% Market Closed

Market Cap: $21.1m

	Vyne Therapeutics Inc NASDAQ:VYNE	US
K	Kohls Corp DUS:KHP	US
	Tessenderlo Group NV XBRU:TESB	BE
L	LifeMD Inc NASDAQ:LFMD	US
	City Union Bank Ltd NSE:CUB	IN
	Tharisa PLC LSE:THS	CY
G	Genting Singapore Ltd OTC:GIGNY	SG
N	NVIDIA Corp XHAM:NVD	US
D	Diageo PLC OTC:DGEAF	UK
U	Unilever PLC F:UNVB	UK
C	CA Sales Holdings Ltd JSE:CAA	ZA
A	American Battery Technology Co NASDAQ:ABAT	US
	Banco Santander SA MAD:SAN	ES
	UTI Asset Management Company Ltd NSE:UTIAMC	IN
C	Cigna Group SWB:CGN	US

Profitability Summary

Vyne Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-5 219%

Negative 3Y Average Operating Margin

-7 453%

Operating Margin is Increasing

-7 678% > -5 219%

Negative Net Margin

-4 646%

Negative 3Y Average Net Margin

-7 060%

Net Margin is Increasing

-8 173% > -4 646%

Negative Free Cash Flow Margin

-5 811%

Negative 3Y Average Free Cash Flow Margin

-6 508%

Free Cash Flow Margin is Increasing

-6 254% > -5 811%

Negative ROE

-66%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-172%

ROIC is Increasing

-481% > -120%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.